Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. AMIX
AMIX logo

AMIX Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Autonomix Medical Inc (AMIX) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Sell
Latest Price
0.400
1 Day change
-3.61%
52 Week Range
2.640
Analysis Updated At
2026/05/29
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

AMIX is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock is a very low-priced microcap with weak trend quality, no recent news catalyst, no positive insider or hedge fund activity, and no supportive analyst or financial visibility in the provided data. With no AI Stock Picker or SwingMax buy signal present, this is not an attractive immediate entry. My direct view: do not buy now.

Technical Analysis

The technical picture is mixed to weak. MACD histogram is positive and expanding, which suggests some short-term momentum improvement, but RSI_6 at 73.147 is elevated and near overbought territory despite being labeled neutral in the data. Moving averages are converging, which usually signals indecision rather than a strong trend. Price closed at 0.4231, just above the prior close of 0.415 and near first resistance at 0.414-0.466. The pivot at 0.329 is well below current price, indicating the stock has already moved off its lower base. Overall, the trend is not strong enough to justify an immediate long-term buy.

Positive Catalysts

  • No news in the recent week, but the MACD histogram is positive and expanding, suggesting some improving near-term momentum. Post-market change was +1.99%, which may indicate limited after-hours interest. The stock is also trading above the pivot level, which is a mild technical positive.

Neutral/Negative Catalysts

  • No recent news catalysts, no significant hedge fund activity, no insider buying trend, no recent congress trading data, no valuation data, and no financial snapshot available. AI Stock Picker shows no signal today, and SwingMax shows no signal recently. Similar candlestick pattern analysis points to weak near-term performance expectations, with projected declines over the next day, week, and month. Price is also close to resistance rather than offering a clear value entry.

Financial Performance

Financial data was not usable because the snapshot returned an error, so the latest quarter cannot be assessed from the provided information. That means there is no confirmed recent-quarter growth trend available for review.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target change data was provided, so Wall Street sentiment cannot be shown as improving. Based on the available inputs, the pros view looks weak: no news catalysts, no insider/hedge support, and no bullish proprietary signal. The cons view is stronger: limited fundamental visibility, low-cap speculative profile, and no evidence of a near-term rerating.

Wall Street analysts forecast AMIX stock price to rise
1 Analyst Rating
Wall Street analysts forecast AMIX stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 0.415
sliders
Low
5
Averages
5
High
5
Current: 0.415
sliders
Low
5
Averages
5
High
5
Maxim
Maxim
Buy
downgrade
$5 -> $2
AI Analysis
2026-02-17
Reason
Maxim
Maxim
Price Target
$5 -> $2
AI Analysis
2026-02-17
downgrade
Buy
Reason
Maxim lowered the firm's price target on Autonomix to $2 from $5 and keeps a Buy rating on the shares. The company's Q3 results were slightly better than expected, though the firm is cutting its price target on expected share dilution from a likely capital raise, the analyst tells investors in a research note.

People Also Watch